ARUP's Laboratory Test Directory

RASA1-Related Disorders (RASA1) Sequencing : 2002730
[ image for: Patient History for RASA1-Related Disorders Testing]
Patient History for RASA1-Related Disorders Testing
  


Mnemonic: RASA1 FGS

Methodology: Polymerase Chain Reaction/Sequencing
Performed: Varies
Reported: Within 28 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data: Background Information for RASA1Related Disorders (RASA1) Sequencing:
Characteristics:
Multifocal, randomly distributed, capillary malformations (CM) that may be associated with a fast-flow lesion (arteriovenous malformations [AVM] or arteriovenous fistula). Fast-flow lesions in the skin, muscle, bone, internal organs or brain can cause life-threatening complications such as bleeding, congestive heart failure, or neurological consequences. Capillary malformation-arteriovenous malformation syndrome (CM-AVM) and Parkes-Weber syndrome may be caused by RASA1 mutations.
Incidence:
Unknown.
Inheritance:
Autosomal dominant; approximately one-third are de novo.
Cause:
Pathogenic RASA1 gene mutations.
Clinical Sensitivity:
75 percent for CM-AVM based on a single study; unknown for other conditions.
Methodology:
Bidirectional sequencing of the entire RASA1 coding region and intron-exon boundaries.
Analytical Sensitivity & Specificity:
99 percent.
Limitations:
Rare diagnostic errors can occur due to primer site mutations. Regulatory region mutations, deep intronic mutations, and large deletions/duplications will not be detected.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Refer to Statement C under Testing Information at http://www.aruplab.com.
CPT Code(s): 83891 Isolation; 83898 x30 Amplification; 83904 x30 Sequencing; 83909 Capillary electrophoresis, 83912 Interpretation and report. Additional CPT code modifiers may be required for procedures performed to test for oncologic or inherited disorders.
Cross References: Capillary Malformation-Arteriovenous Malformation Syndrome (RASA1-Related Disorders (RASA1) Sequencing) , Parkes-Weber Syndrome (RASA1-Related Disorders (RASA1) Sequencing)
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org